Published in Anal Biochem on February 01, 1976
Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim Biophys Acta (1971) 6.67
Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ (1992) 6.33
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol (1990) 3.25
The Lidköping Accident Prevention Programme--a community approach to preventing childhood injuries in Sweden. Inj Prev (1995) 3.09
Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom (1999) 3.05
Agarose gel electrophoresis. Scand J Clin Lab Invest Suppl (1972) 2.32
School accidents during a three school-years period in a Swedish municipality. Public Health (1991) 2.15
Sequential changes of plasma proteins after myocardial infarction. Scand J Clin Lab Invest Suppl (1972) 1.79
Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol (1988) 1.77
Making sense of safety. Inj Prev (2004) 1.63
Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci (1994) 1.61
Cardiovascular disease in developing countries. BMJ (1993) 1.59
Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut (2004) 1.59
Growth hormone treatment affects brain neurotransmitters and thyroxine [see comment]. Clin Endocrinol (Oxf) (1996) 1.46
Nature of the tumor-associated determinant(s) of carcinoembryonic antigen. Proc Natl Acad Sci U S A (1975) 1.43
[Fatty acids and confusing signals]. Ugeskr Laeger (1995) 1.40
Elevated CSF somatostatin concentrations in demented patients parallel improved psychomotor functions induced by integrity-promoting care. Acta Psychiatr Scand (1989) 1.38
[How reliable is the laboratory? Increased needs of patient-related quality assurance]. Lakartidningen (1999) 1.38
Blood glucose measurement with Dextrostix and new reflectance meter. Br Med J (1974) 1.34
Experimental porcine nephropathy. Changes of renal function and structure induced by ochratoxin A- contaminated feed. Acta Pathol Microbiol Scand Suppl (1974) 1.33
Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc Natl Acad Sci U S A (1994) 1.33
Multiple tachykinin pools in sensory nerve fibres in the rabbit iris. Neuroscience (1987) 1.32
Topical anesthesia with lidocaine aerosol in the control of postoperative pain. Anesthesiology (1988) 1.27
Unintentional home-related injuries in the Islamic Republic of Iran: findings from the first year of a national programme. Public Health (2005) 1.26
Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J Cereb Blood Flow Metab (1987) 1.26
Glomerulonephritis and exposure to organic solvents. A case-control study. Acta Med Scand (1979) 1.24
Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress. Neuroreport (1999) 1.18
Quantitative immunochemical determination of lysoqyme (muramidase) in serum and urine. Scand J Clin Lab Invest (1971) 1.17
Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. J Neural Transm (Vienna) (1996) 1.16
Changes in plasma high density lipoproteins in chronic male alcoholics during and after abuse. Scand J Clin Lab Invest (1978) 1.16
Projections of peptide-containing neurons in rat small intestine. Neuroscience (1987) 1.16
Projections of peptide-containing neurons in rat colon. Neuroscience (1988) 1.16
Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung. Acta Pathol Microbiol Immunol Scand A (1985) 1.14
Prevention-oriented epidemiology of burns in Ardabil provincial burn centre, Iran. Burns (2010) 1.14
Occurrence and distribution of neuropeptides in the human skin. An immunocytochemical and immunochemical study on normal skin and blister fluid from inflamed skin. Acta Derm Venereol (1987) 1.12
Quotation bias in reviews of the diet-heart idea. J Clin Epidemiol (1995) 1.11
Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology (1996) 1.11
Hydrocarbon exposure and glomerulonephritis: evidence from patients' occupations. Lancet (1983) 1.10
Isolation of crystalline lactoferrin from human milk. Acta Chem Scand (1969) 1.08
Treatment of glomerulonephritis with drainage of the thoracic duct and plasmapheresis. Acta Med Scand (1977) 1.08
Spurious results of digoxin radioimmunoassay. N Engl J Med (1984) 1.08
Improvement of glomerulonephritis after discontinuation of solvent exposure. Lancet (1979) 1.08
Peptide-containing nerve fibers in human cerebral arteries: immunocytochemistry, radioimmunoassay, and in vitro pharmacology. Ann Neurol (1987) 1.07
[The Scandinavian Simvastatin Survival Study (4S): hasty conclusions]. Ugeskr Laeger (1995) 1.07
[Stop the cholesterol campaign!]. Lakartidningen (1993) 1.07
Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett (1985) 1.07
Prevention oriented epidemiologic study of accidental burns in rural areas of Ardabil, Iran. Burns (2006) 1.07
Corticotropin, cortisol and beta-endorphin responses to the human corticotropin-releasing hormone during melancholia and after unilateral electroconvulsive therapy. Acta Psychiatr Scand (1990) 1.06
Reduction and proteolytic degradation of immunoglobulin A from human colostrum. Acta Chem Scand (1966) 1.06
Detection and quantification of neurotensin in human brain tissue by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Chem (2000) 1.06
Road traffic accidents in a Swedish municipality. Public Health (1990) 1.05
Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis. Electrophoresis (1997) 1.04
Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J Psychiatr Res (1988) 1.03
Interaction of streptococci with the Fc fragment of IgG. Acta Pathol Microbiol Scand C (1976) 1.02
The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis. Clin Nephrol (1981) 1.02
Medicinal iron to low birth weight infants. Acta Paediatr Scand (1979) 1.02
Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders? J Neural Transm Park Dis Dement Sect (1994) 1.01
Depletion of neuropeptides in rat parotid glands and declining atropine-resistant salivary secretion upon continuous parasympathetic nerve stimulation. Regul Pept (1985) 1.00
Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue. Clin Chim Acta (1975) 0.98
Disturbed motilin and cholecystokinin release in the irritable bowel syndrome. Scand J Gastroenterol (1996) 0.98
Calcitonin gene-related peptide in thyroid nerve fibers and C cells: effects on thyroid hormone secretion and response to hypercalcemia. Endocrinology (1986) 0.97
alpha1-Microglobulin, a new low molecular weight plasma protein. Clin Chim Acta (1976) 0.97
Exposure to organic solvents--a missing link in poststreptococcal glomerulonephritis? Acta Med Scand (1978) 0.96
Plasma beta-endorphin during clinical and experimental ischaemic pain. Scand J Clin Lab Invest (1987) 0.95
Calcitonin gene-related peptide in the eye: release by sensory nerve stimulation and effects associated with neurogenic inflammation. Regul Pept (1986) 0.94
Disorders of serum alpha-lipoproteins after alcoholic intoxication. Scand J Clin Lab Invest (1969) 0.94
Capsaicin evokes secretion of nasal fluid and depletes substance P and calcitonin gene-related peptide from the nasal mucosa in the rat. Br J Pharmacol (1989) 0.94
Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries. Ann Neurol (1986) 0.94
No evident neuronal damage after electroconvulsive therapy. Psychiatry Res (2000) 0.93
Aneurysm of the heart and the post-myocardial infarction syndrome. Acta Med Scand (1968) 0.92
The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains. Schizophr Res (1999) 0.92
Increase in plasma alpha-lipoproteins in chronic alcoholics after acute abuse. Acta Med Scand (1974) 0.92
Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress. Regul Pept (1998) 0.92
What do angiographic changes after cholesterol lowering mean? Lancet (1994) 0.92
A CE-MALDI interface based on the use of prestructured sample supports. Anal Chem (2001) 0.91
Calcitonin gene-related peptide in rat salivary glands: neuronal localization, depletion upon nerve stimulation, and effects on salivation in relation to substance P. Neuroscience (1988) 0.91
Implications of 4S evidence on baseline lipid levels. Lancet (1995) 0.90
Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics. Acta Psychiatr Scand (1991) 0.90
Catecholaminergic suppression of immunocompetent cells. Immunol Today (1998) 0.90
Neuropeptides in idiopathic chronic constipation (slow transit constipation). Neurogastroenterol Motil (1997) 0.89
Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone. Am J Obstet Gynecol (1985) 0.89
Interaction of lactoferrin with agar gels and with Trypan Blue. Biochim Biophys Acta (1971) 0.89
Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res (1987) 0.89
ECT in Parkinson's disease. Changes in motor symptoms, monoamine metabolites and neuropeptides. J Neural Transm Park Dis Dement Sect (1995) 0.88
Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism. Br J Clin Pharmacol (1999) 0.88
Neuronal gastrin-releasing peptide in the mammalian gut and pancreas. Neuroscience (1983) 0.88
Experimental porcine nephropathy: changes of renal function and structure perorally induced by crystalline ochratoxin A. Acta Pathol Microbiol Scand A (1976) 0.88
CGRP and somatostatin modulate chronic hypoxic pulmonary hypertension. Am J Physiol (1992) 0.87
Porcine nephropathy induced by long-term ingestion of ochratoxin A. Vet Pathol (1979) 0.87
Bombesin, neurotensin and pro-gamma-melanotropin immunoreactants in human milk. Regul Pept (1985) 0.87
Correlations between plasma-neuropeptides and temperament dimensions differ between suicidal patients and healthy controls. J Affect Disord (1998) 0.87
Vasoactive intestinal peptide and substance P in salivary glands of the rat following denervation or duct ligation. Regul Pept (1984) 0.87
Motilin in chronic idiopathic constipation. Scand J Gastroenterol (1986) 0.86
Chromogranin A in cerebrospinal fluid: a biochemical marker for synaptic degeneration in Alzheimer's disease? Dementia (1996) 0.86
Regulatory peptides in the lower esophageal sphincter of man. Regul Pept (1985) 0.86
Peptide YY-like immunoreactivity in the central nervous system of the rat. Regul Pept (1986) 0.86
Neuropeptides in the human appendix. Distribution and motor effects. Dig Dis Sci (1989) 0.86
Electromagnetic hypersensitive Finns: Symptoms, perceived sources and treatments, a questionnaire study. Pathophysiology (2013) 0.86